Short Interest in BioRestorative Therapies, Inc. (NASDAQ:BRTX) Decreases By 28.9%

BioRestorative Therapies, Inc. (NASDAQ:BRTX) saw a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 109,000 shares, a drop of 28.9% from the December 15th total of 153,400 shares. Based on an average daily volume of 52,400 shares, the days-to-cover ratio is currently 2.1 days. Approximately 2.2% of the shares of the company are sold short.

BioRestorative Therapies Stock Performance

Shares of BRTX stock traded down $0.02 during trading on Wednesday, hitting $1.80. The company had a trading volume of 99,399 shares, compared to its average volume of 55,222. The firm has a market capitalization of $12.46 million, a P/E ratio of -1.18 and a beta of 63.13. BioRestorative Therapies has a one year low of $1.03 and a one year high of $3.67. The stock’s 50-day moving average price is $1.53 and its 200 day moving average price is $1.60.

BioRestorative Therapies (NASDAQ:BRTX) last released its earnings results on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.22. The firm had revenue of $0.23 million during the quarter, compared to the consensus estimate of $0.30 million. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. On average, research analysts anticipate that BioRestorative Therapies will post -1.43 earnings per share for the current fiscal year.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.